Author

Irina Isakova-Sivak

Institute of Experimental Medicine - Cited by 1,401 - Virology - immunology - reverse genetics - viral vaccines

Biography

She is currently working as a Professor in the Department of Medicine. Her research interests includes Medicine.she is serving as an editorial member and reviewer of several international reputed journals.She has successfully completed his Administrative responsibilities.She has authored of many research articles/books related to Medicine.
Title
Cited by
Year
M2e-based universal influenza vaccines: a historical overview and new approaches to development
D Mezhenskaya, I Isakova-Sivak, L RudenkoJournal of biomedical science 26 (1), 1-15, 2019201
80
2019
Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine
D Korenkov, I Isakova-Sivak, L RudenkoExpert review of vaccines 17 (11), 977-987, 2018201
45
2018
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin
I Isakova-Sivak, D Korenkov, T Smolonogina, T Kotomina, S Donina, ...Virology 518, 313-323, 2018201
35
2018
Immunogenicity and cross protection in mice afforded by pandemic H1N1 live attenuated influenza vaccine containing wild-type nucleoprotein
A Rekstin, I Isakova-Sivak, G Petukhova, D Korenkov, I Losev, ...BioMed research international 2017, 2017201
25
2017
A promising inactivated whole-virion SARS-CoV-2 vaccine
I Isakova-Sivak, L RudenkoThe Lancet Infectious Diseases 21 (1), 2-3, 2021202
25
2021
Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type …
I Isakova-Sivak, D Korenkov, T Smolonogina, T Tretiak, S Donina, ...Virology 500, 209-217, 2017201
24
2017
Sequential immunization with universal live attenuated influenza vaccine candidates protects ferrets against a high-dose heterologous virus challenge
I Isakova-Sivak, V Matyushenko, T Kotomina, I Kiseleva, E Krutikova, ...Vaccines 7 (3), 61, 2019201
24
2019
Immunogenicity and viral shedding of Russian-backbone, seasonal, trivalent, live, attenuated influenza vaccine in a phase II, randomized, placebo-controlled trial among …
KDC Lewis, JR Ortiz, MZ Rahman, MZ Levine, L Rudenko, PF Wright, ...Clinical Infectious Diseases 69 (5), 777-785, 2019201
22
2019
Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease
T Kotomina, I Isakova-Sivak, V Matyushenko, KH Kim, Y Lee, YJ Jung, ...Antiviral research 168, 9-17, 2019201
21
2019
Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS …
V Matyushenko, I Isakova-Sivak, I Kudryavtsev, A Goshina, A Chistyakova, ...Viruses 13 (8), 1490, 212
20
2021
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the …
T Kotomina, D Korenkov, V Matyushenko, P Prokopenko, L Rudenko, ...Human vaccines & immunotherapeutics 14 (12), 2964-2970, 181
20
2018
Overview of human rhinovirus immunogenic epitopes for rational vaccine design
E Stepanova, I Isakova-Sivak, L RudenkoExpert review of vaccines 18 (9), 877-880, 202
19
2019
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized …
V Matyushenko, T Kotomina, I Kudryavtsev, D Mezhenskaya, ...Antiviral Research 182, 104864, 2020202
19
2020
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
BR Park, KH Kim, T Kotomina, MC Kim, YM Kwon, S Jeeva, YJ Jung, ...Scientific Reports 11 (1), 4151, 2021202
18
2021
Dysregulated immune responses in SARS-CoV-2-infected patients: a comprehensive overview
I Kudryavtsev, A Rubinstein, A Golovkin, O Kalinina, K Vasilyev, ...Viruses 14 (5), 1082, 2022202
16
2022
Tackling a novel lethal virus: a focus on H7N9 vaccine development
I Isakova-Sivak, L RudenkoExpert Review of Vaccines 16 (7), 709-721, 2017201
14
2017
Construction and immunogenicity of a novel multivalent vaccine prototype based on conserved Influenza virus antigens
A Kirsteina, I Akopjana, J Bogans, I Lieknina, J Jansons, D Skrastina, ...Vaccines 8 (2), 197, 2020202
14
2020
Safety, immunogenicity and protection of A (H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model
DA Korenkov, KL Laurie, PC Reading, LA Carolan, KF Chan, ...Infection, Genetics and Evolution 64, 95-104, 2018201
13
2018
Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines
I Isakova-Sivak, E Grigorieva, L RudenkoExpert Review of Vaccines 19 (1), 43-55, 2020202
13
2020
Cross-reactivity of SARS-CoV-2 nucleocapsid-binding antibodies and its implication for COVID-19 serology tests
A Rak, S Donina, Y Zabrodskaya, L Rudenko, I Isakova-SivakViruses 14 (9), 2041, 2022202
12
2022

Referred From: https://scholar.google.com/citations?hl=en&user=6X6C--kAAAAJ

Cited by
Citations 1401
h-index 23
i10-index 46
Recommended Journals
Open Access Journals